You have read all your free articles, to continue reading subscribe to read the rest of this content.
Nexstim announces that it is raising new equity financing of the gross amount EUR 1.75 million via a directed issue of new shares to a London-based fund managed by City Financial Investment Company Limited. The Company’s Board of Directors resolved to issue up to 7,000,000 new shares at a subscAlready…
Swedish iCellate Medical has together with the Swiss biopharmaceutical company Elthera (and consortium) received a grant of 25 MSEK from Eurostars to develop a new second generation immunotherapy drug for pancreatic and ovarian cancers. In the evaluation process Eurostars rated iCellate’s projeAlready a subscriber Login You have read all your…
AstraZeneca and Takeda Pharmaceutical have entered an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD). Alpha-synuclein (α-synuclein) is an aggregation-prone protein that contribuAlready a subscriber Login You have read all your free articles, to continue reading subscribe…
Dignitana has received clearance from the U.S. Food and Drug Administration (FDA) to expand use of its medical device to patients in the United States receiving chemotherapy for solid tumor cancers. Originally cleared in December 2015 by the FDA as the first scalp cooling device for use in womeAlready a subscriber Login…
